Edwards Lifesciences
1,266 hedge funds and large institutions have $48.2B invested in Edwards Lifesciences in 2022 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 445 increasing their positions, 477 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,266
Holders Change
-42
Holders Change %
-3.21%
% of All Funds
21.41%
Holding in Top 10
22
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-15.38%
% of All Funds
0.37%
New
114
Increased
445
Reduced
477
Closed
137
Calls
$182M
Puts
$195M
Net Calls
-$13M
Net Calls Change
-$113M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$595M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
$1.56B |
| 3 |
Norges Bank
Oslo,
Norway
|
$818M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$843M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
$116M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$755M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
$35M |
| 3 |
BlackRock
New York
|
$5.3B |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
$1.31B |
| 5 |
Man Group
London,
United Kingdom
|
$97.3M |
